These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 6250050)

  • 1. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.
    Ford-Hutchinson AW; Bray MA; Doig MV; Shipley ME; Smith MJ
    Nature; 1980 Jul; 286(5770):264-5. PubMed ID: 6250050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages.
    Doig MV; Ford-Hutchinson AW
    Prostaglandins; 1980 Dec; 20(6):1007-19. PubMed ID: 6259695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxygenase products and the polymorphonuclear leucocyte.
    Ford-Hutchinson AW; Bray MA; Smith MJ
    Agents Actions; 1980 Dec; 10(6):548-50. PubMed ID: 6267913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid, leukotriene B4, and neutrophil activation.
    Naccache PH; Sha'afi RI
    Ann N Y Acad Sci; 1983; 414():125-39. PubMed ID: 6322649
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutrophil aggregating and chemokinetic properties of a 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid isolated from human leukocytes.
    Camp RD; Woollard PM; Mallet AI; Fincham NJ; Ford-Hutchinson AW; Bray MA
    Prostaglandins; 1982 May; 23(5):631-41. PubMed ID: 6289379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils.
    Prescott SM; Zimmerman GA; Seeger AR
    Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium ionophore A23187 induces release of chemokinetic and aggregating factors from polymorphonuclear leucocytes.
    Bray MA; Ford-Hutchinson AW; Shipley ME; Smith MJ
    Br J Pharmacol; 1980; 71(2):507-12. PubMed ID: 6781577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for the chemotactic activity of cyclooxygenase- and lipoxygenase-dependent compounds using a corneal implantation technique.
    Rochels R; Busse WD
    Ophthalmic Res; 1984; 16(4):194-7. PubMed ID: 6089067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isomers of leukotriene B4 possess different biological potencies.
    Ford-Hutchinson AW; Bray MA; Cunningham FM; Davidson EM; Smith MJ
    Prostaglandins; 1981 Jan; 21(1):143-52. PubMed ID: 6259698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokinetic activity of arachidonic and lipoxygenase products on leuocyctes of different species.
    Palmer RM; Stepney RJ; Higgs GA; Eakins KE
    Prostaglandins; 1980 Aug; 20(2):411-8. PubMed ID: 6251514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
    Lee TH; Menica-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Biol Chem; 1984 Feb; 259(4):2383-9. PubMed ID: 6321468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J; Udén AM; Friberg I; Ringertz B; Rådmark O; Lindgren JA; Hansson G; Malmsten CL
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():25-31. PubMed ID: 6303087
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
    J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities of isomers of 8,15-dihydroxyeicosatetraenoic acid.
    Evans J; Ford-Hutchinson AW; Fitzsimmons B; Rokach J
    Prostaglandins; 1984 Sep; 28(3):435-8. PubMed ID: 6096926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and omega-oxidized metabolites.
    Rosolowsky M; Falck JR; Campbell WB
    Biochim Biophys Acta; 1996 Apr; 1300(2):143-50. PubMed ID: 8652640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes.
    Bokoch GM; Reed PW
    J Biol Chem; 1981 Jun; 256(11):5317-20. PubMed ID: 6787038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in arachidonic acid release, metabolism and leukotriene B4 synthesis in human polymorphonuclear leukocytes activated by different stimuli.
    Sellmayer A; Strasser T; Weber PC
    Biochim Biophys Acta; 1987 Mar; 927(3):417-22. PubMed ID: 3028498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.